Fosun 复星’s Post

Recently, JelloX Biotech Inc. visited Japan to explore potential partnerships! 🇯🇵 Our journey was filled with enriching experiences as we delved into the vibrant landscape of Japanese innovation and collaboration. From engaging discussions with industry leaders to immersing ourselves in the rich culture, every moment was an opportunity to forge meaningful connections. We're truly inspired by the innovative spirit we encountered and are eager to explore how we can synergize our expertise with that of our potential partners in Japan. Stay tuned for more updates as we embark on this promising journey together! #JapanPartnership #InnovationJourney #DigitalPathology #AI #Cancer #Biotech #FightingForHuman #Japan #NationalCancerCenterJapan 🚀🔬

#GLINInvestingTeam GLIN Impact Capital Invests in U.S.-based Earli Inc., Developer of Advanced Cancer Detection Technology Through this investment, GLIN Impact Capital aims to drive impact by enhancing the company’s value from an impact/ESG perspective and supporting its potential entry into the Japanese market, with the goal of improving cancer survival rates and reducing side effects of treatment worldwide. Below is the release in Japanese.  https://lnkd.in/g_psV2X6 #impactinvesting

WO2023114871 - USE OF COMBINATION THERAPY FOR TREATING CANCER Publication No. (Date): WO/2023/114871 (22 June 2023) Int. Appl. No. (Date): PCT/US2022/081592 (14 December 2022) Applicant(s): RECURIUM IP HOLDINGS, LLC Agent(s): MILLER, Kimberly, J. Priority Date: 15 December 2021 Publication Language: English (en) Filing Language: English (en) #RECURIUMIPHOLDINGS,LLC #WO2023114871 #USEOFCOMBINATIONTHERAPYFORTREATINGCANCER #KoreanNationalPhase #KoreanPCT #KoreanIP #PatentEntry #NationalPhaseEntry #KoreanPatent #PCTKorea

Excited to be at the intersection of Science and Business today at the #BusinessofBiotech at Moffitt Cancer Center! Excellent Keynote by Amgen CEO Bob Bradway interviewed by OncoBay Clinical CEO Krystyna Kowalczyk Question: “What is the first thing you would do if you were going to start a new company?” Answer: “You have to have the best people! Great people attract other Great People.” I could not have said it better myself!! Capital and HUMAN Capital are KING in start ups!! FloodGate Medical #biotechrecruitment #talentdevelopment #scienceinnovation #humancapital

❗ Save the Date! ↗️ “Stakeholder Roundtable: Biomarkers - Co-creating the Framework” ⤴️ 🗓️Wednesday, November 6. 📍“Stratos Vassilikos” hotel, Athens. All.Can Greece will host a Roundtable, titled: "Biomarkers - Co-creating the Framework". The event will focus on the need to establish a new framework for the approval and reimbursement of biomarkers in Greece, building on the synergies and initiatives that have been undertaken by the oncology and academic communities to date. ℹ️ Stay tuned for more information! #allcangreece #ellok #stakeholderoundtable #Biomarkers_CoCreating_The_Framework

“While the global financial injection of $600 million is a monumental step, tangible progress hinges on addressing the realities faced by LMICs: logistics hurdles, cultural barriers, local leadership ownership, data & evidence” - Zainab Shinkafi-Bagudu in her commentary published in the ASCO JCO Global Oncology Journal. Read the full article: https://lnkd.in/gs6v8bb9 I agree with her viewpoints, there is a need for a lot of funding for vaccination, but there is also a need for technical support and funding for other areas of cervical cancer elimination. Please use the comment section to share your thoughts on this commentary. Thanks for always speaking up for Africa and LMICs. #ChokeCancer

🆕 During the month of March, at the #BioRegionCatalonia, new and outstanding developments in #research have taken place. Let’s review them 👇 🔺 The Hospital Clínic de Barcelona has started a clinical trial with a CAR-T therapy for lymphoma that is pioneering in the world. 🔺 The Blood and Tissue Bank (Banc de Sang i Teixits) and Institut de Recerca Sant Pau have teamed up to promote the production of innovative drugs and advanced therapies, including CAR-T cells. 🔺 The IRB Barcelona has promoted a pioneering program in Europe in translational research, which aims to accelerate the arrival of results to patients. 🔺 Also, we are celebrating the fact that #Barcelona has regained its leadership in applications for European patents in Spain, according to the European Patent Office. Read these and more news at the wrap up of March: https://ow.ly/1rFv50R36Iq

🚨 The #EuropeanSustainableDevelopmentWeek (ESDW) is underway! 🌍 The goal of the #ESDW is to provide a platform and make exemplary #commitment visible throughout all of #Europe within a certain period of time (18 September – 8 October), to attract #publicattention to the topic of #sustainabledevelopment, the #UN2030Agenda, and the 17 #SustainableDevelopmentGoals (SDGs). Everyone can change something for the better! 💪 ☝ We at #ARTTICInnovation have committed ourselves to the #SDGs across our #fundedprojects and are sending out a stronger signal #together with our consortium partners: ⚕ SDG3 “Good #health and well-being”: AIMS-2-TRIALS, The CANDY project, European Lead Factory, OPTIMA Oncology, PIONEER - Big Data in Prostate Cancer, R2D2-MH Project, i.a. 💡 SDG7 “Affordable and #cleanenergy”: DECAGONE, FLEX4H2, HYFLEXPOWER Project , i.a. 🏭 SDG9 “#Industry, #innovation, and #infrastructure”: all our funded projects, see here ➡ https://lnkd.in/dHAFf88r ☀ SDG13 “#Climateaction”: Forest NavigatorEU, i.a.

#Opportunity to #join #research #Team If you're interested in working with research team on a project related to #developing #evidence for #lung #cancer, particularly #non-#small #cell #lung #cancer Kindly reply to this post. #SLCA #TheAmericanLungAssociation #lungcancer #Non #Small #cell #lung #Cancer #ISPORannual #ISPOR2024 #HEOR #Middleast #market #pharma #marketaccess #ispor #ICER #economics #healthcareconsulting #pharmacoeconomics #isporeurope #healtheconomics #EvidenceGeneration #EconomicsEvaluation #Modeling #Pricingandreimbursement #drreemalmutairi Vassiki S. Vakaramoko (Karam) Diaby

ISO 15189 is vital for precision medicine, ensuring accurate diagnostics and enhanced patient safety through rigorous quality standards.